Sargent Bickham Lagudis’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-140
Closed -$7K 796
2020
Q2
$7K Hold
140
﹤0.01% 612
2020
Q1
$7K Hold
140
﹤0.01% 601
2019
Q4
$7K Hold
140
﹤0.01% 649
2019
Q3
$7K Hold
140
﹤0.01% 596
2019
Q2
$7K Hold
140
﹤0.01% 624
2019
Q1
$7K Hold
140
﹤0.01% 653
2018
Q4
$6K Hold
140
﹤0.01% 634
2018
Q3
$8K Hold
140
﹤0.01% 634
2018
Q2
$7K Hold
140
﹤0.01% 627
2018
Q1
$9K Hold
140
﹤0.01% 596
2017
Q4
$9K Hold
140
﹤0.01% 621
2017
Q3
$9K Hold
140
﹤0.01% 624
2017
Q2
$11K Hold
140
﹤0.01% 556
2017
Q1
$11K Sell
140
-58
-29% -$4.57K ﹤0.01% 573
2016
Q4
$14K Buy
198
+1
+0.5% +$72 ﹤0.01% 511
2016
Q3
$15K Hold
197
﹤0.01% 509
2016
Q2
$15K Hold
197
﹤0.01% 494
2016
Q1
$16K Buy
+197
New +$16K ﹤0.01% 500

Other funds holding CAH

Sargent Bickham Lagudis's CAH Position: Q3 2020 in Review

Sargent Bickham Lagudis sold out of Cardinal Health (CAH) in Q3 2020, closing a stake of 140 shares — an estimated $7K sold.

Sargent Bickham Lagudis first reported a position in CAH in Q1 2016 and held it in 18 quarters. The position peaked at $16K in Q1 2016. 741 funds tracked by Wall St. Rank hold CAH as of Q3 2020.

  • Sargent Bickham Lagudis reported no remaining Cardinal Health position as of Q3 2020 after selling out during the quarter.
  • Sargent Bickham Lagudis sold 140 Cardinal Health shares in Q3 2020, an estimated $7K.
  • Sargent Bickham Lagudis first reported a position in Cardinal Health in Q1 2016 and held it in 18 quarters.
  • Sargent Bickham Lagudis's Cardinal Health position peaked at $16K in Q1 2016.
  • 741 funds tracked by Wall St. Rank held Cardinal Health as of Q3 2020.

Based on Sargent Bickham Lagudis's 13F filing for Q3 2020, filed 1 Sep 2021.